Home > NRC Library > ADAMS Public Documents

06-05869-03 583584 Pfizer, Inc. (Term.)

Accession Number: ML14094A422

Date Released: Monday, October 20, 2014

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML14094A454 - Pfizer, Inc.; Termination Request Letter dated 03/24/2014. (81 page(s), 3/24/2014)
• ML14189A111 - Response to Technical Assistance Request, dated March 24, 2014, for the Review of DCGL Values for the Pfizer, Inc. Cyclotron Facility in Groton CT. (12 page(s), 7/10/2014)
• ML14202A290 - Pfizer, Inc.; E-mail dtd July 14, 2014, RE: Deficiency Request - Cyclotron Termination, Control No. 583584. (3 page(s), 4/14/2014)
• ML14204A697 - Pfizer, Inc.; E-mail dtd July 17, 2014, RE: Cyclotron Termination - Additional Questions Regarding Potentially- Contaminated Steel in Vault; Control No. 583584. (4 page(s), 7/17/2014)
• ML14260A125 - Pfizer Inc., Deficiency Response Letter dtd September 4, 2014, Control No. 583584. (16 page(s), 9/4/2014)
• ML14266A374 - Final Response to Technical Assistance Request, Dated March 24, 2014, for the review of Derived Concentration Guideline Levels for the Release of the Pfizer, Inc., Eclipse Cyclotron Vault, Groton, Connecticut. (10 page(s), 9/25/2014)
• ML14289A144 - Pfizer, Inc., License Termination, Control No. 583584. (2 page(s), 10/9/2014)
• ML14289A161 - Pfizer, Inc., Amendment No. 6, Mail Control No. 583584. (1 page(s), 10/9/2014)